Total expenses climbed 17.55% to Rs 209.82 crore in Q2 FY26, compared with Rs 178.50 crore in Q2 FY25. Cost of material consumed stood at Rs 106.56 crore (down 32.88% YoY), manufacturing expenses stood at Rs 25.73 crore (up 17.01% YoY), employee benefit expenses was at Rs 19.25 crore (up 7.42% YoY) and finance cost stood at Rs 5.73 crore (up 24.57% YoY) during the period under review.
On half yearly basis, the company’s consolidated net profit jumped 49.8% to Rs 45.80 crore on 21.4% increase in revenue from operations to Rs 438.48 crore in H1 FY26 over H1 FY25.
SMS Pharmaceuticals is a diversified and integrated pharmaceutical company specializing in APIs and intermediates for global customers. The company operates two state-of-the-art manufacturing facilities in Hyderabad and Vizag.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."